ACC1-expressing pathogenic T helper 2 cell populations facilitate lung and skin inflammation in mice

Abstract
T cells possess distinguishing effector functions and drive inflammatory disorders. We have previously identified IL-5–producing Th2 cells as the pathogenic population predominantly involved in the pathology of allergic inflammation. However, the cell-intrinsic signaling pathways that control the pathogenic Th2 cell function are still unclear. We herein report the high expression of acetyl-CoA carboxylase 1 (ACC1) in the pathogenic CD4+ T cell population in the lung and skin. The genetic deletion of CD4+ T cell–intrinsic ACC1 dampened eosinophilic and basophilic inflammation in the lung and skin by constraining IL-5 or IL-3 production. Mechanistically, ACC1-dependent fatty acid biosynthesis induces the pathogenic cytokine production of CD4+ T cells via metabolic reprogramming and the availability of acetyl-CoA for epigenetic regulation. We thus identified a distinct phenotype of the pathogenic T cell population in the lung and skin, and ACC1 was shown to be an essential regulator controlling the pathogenic function of these populations to promote type 2 inflammation.
Funding Information
  • Ministry of Education, Culture, Sports, Science and Technology (18H04665, 20H03455, 20K21618, 26221305, JP19H05650)
  • The Nakajima Foundation
  • Terumo Foundation for Life Sciences and Arts
  • Tokyo Biochemical Research Foundation
  • Kato Memorial Bioscience Foundation
  • Hamaguchi Foundation for the Advancement of Biochemistry
  • Suzuken Memorial Foundation
  • Kanae Foundation for the Promotion of Medical Science
  • Takeda Science Foundation
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • GlaxoSmithKline Japan (2019)
  • SENSHIN Medical Research Foundation
  • Sumitomo Foundation
  • Koyanagi Foundation
  • Kishimoto Foundation 2019
  • Uehara Memorial Foundation
  • Nakatomi Foundation
  • Research Foundation for Pharmaceutical Sciences Group A
  • Cell Science Research Foundation
  • Astellas Foundation for Research on Metabolic Disorders
  • MSD Life Science Foundation, Public Interest Incorporated Foundation
  • Nagase Science Technology Foundation
  • Japan Agency for Medical Research and Development (JP21ek0410060)
  • AMED-CREST (JP21gm1210003)

This publication has 54 references indexed in Scilit: